AIM: To evaluate the anticancer property of the dried latex (DL) of Calotropis procera, a tropical medicinal plant, in the X15-myc transgenic mouse model of hepatocellular carcinoma and to elucidate its mechanism of action in cell culture. METHODS: The young transgenic mice were orally fed with the aqueous suspension of DL (400 mg/kg for 5 d/wk) for 15 wk and their liver was examined for histopathological changes at 20 wk. Serum levels of vascular endothelial growth factor (VEGF) were also measured in these animals. To characterize the active fraction, DL was extracted with petroleum ether followed by methanol. The methanolic extract was sub-fractionated on a silica gel G column using a combination of non-polar and polar solvents and eleven fractions were obtained. Each fraction was analysed for cytotoxic effect on hepatoma (Huh7) and non-hepatoma (COS-1) cell lines and non-transformed hepatocytes (AML12) using tetrazolium (MTT) assay. Finally, the mechanism of cell death was investigated by measuring the levels of Bcl2, caspase 3 and DNA fragmentation. RESULTS: DL treatment of mice showed a complete protection against hepatocarcinogenesis. No adverse effect was observed in these animals. The serum VEGF level was significantly lowered in the treated mice as compared to control animals. Cell culture studies revealed that the methanolic extract of DL as well as its fraction 8 induced extensive cell death in both Huh-7 and COS-1 cells while AML12 cells were spared. This was accompanied by extensive fragmentation of DNA in Huh-7 and COS-1 cells. No change in the levels of canonical markers of apoptosis such as Bcl2 and caspase 3 was observed. CONCLUSION: DL of C. procera has the potential for anti-cancer therapy due to its differentiable targets and non-interference with regular pathway of apoptosis.
AIM: To evaluate the anticancer property of the dried latex (DL) of Calotropis procera, a tropical medicinal plant, in the X15-myc transgenic mouse model of hepatocellular carcinoma and to elucidate its mechanism of action in cell culture. METHODS: The young transgenic mice were orally fed with the aqueous suspension of DL (400 mg/kg for 5 d/wk) for 15 wk and their liver was examined for histopathological changes at 20 wk. Serum levels of vascular endothelial growth factor (VEGF) were also measured in these animals. To characterize the active fraction, DL was extracted with petroleum ether followed by methanol. The methanolic extract was sub-fractionated on a silica gel G column using a combination of non-polar and polar solvents and eleven fractions were obtained. Each fraction was analysed for cytotoxic effect on hepatoma (Huh7) and non-hepatoma (COS-1) cell lines and non-transformed hepatocytes (AML12) using tetrazolium (MTT) assay. Finally, the mechanism of cell death was investigated by measuring the levels of Bcl2, caspase 3 and DNA fragmentation. RESULTS: DL treatment of mice showed a complete protection against hepatocarcinogenesis. No adverse effect was observed in these animals. The serum VEGF level was significantly lowered in the treated mice as compared to control animals. Cell culture studies revealed that the methanolic extract of DL as well as its fraction 8 induced extensive cell death in both Huh-7 and COS-1 cells while AML12 cells were spared. This was accompanied by extensive fragmentation of DNA in Huh-7 and COS-1 cells. No change in the levels of canonical markers of apoptosis such as Bcl2 and caspase 3 was observed. CONCLUSION: DL of C. procera has the potential for anti-cancer therapy due to its differentiable targets and non-interference with regular pathway of apoptosis.
Authors: A A van de Loosdrecht; R H Beelen; G J Ossenkoppele; M G Broekhoven; M M Langenhuijsen Journal: J Immunol Methods Date: 1994-09-14 Impact factor: 2.303
Authors: G Deplanque; S Madhusudan; P H Jones; S Wellmann; K Christodoulos; D C Talbot; T S Ganesan; A Blann; A L Harris Journal: Br J Cancer Date: 2004-11-01 Impact factor: 7.640
Authors: Carolina Araújo Viana; Márcio V Ramos; José Delano Barreto Marinho Filho; Letícia Veras Costa Lotufo; Ingrid Samantha Tavares Figueiredo; Jefferson Soares de Oliveira; Pietro Mastroeni; José Vitor Lima-Filho; Nylane Maria Nunes Alencar Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2017-07-11 Impact factor: 3.000
Authors: Asmat Ullah Khan; Muhammad Akram; Muhammad Daniyal; Naheed Akhter; Muhammad Riaz; Naheed Akhtar; Mohammad Ali Shariati; Fozia Anjum; Samreen Gul Khan; Abida Parveen; Saeed Ahmad Journal: Metab Brain Dis Date: 2019-10-11 Impact factor: 3.584
Authors: Raquel S B Oliveira; Ingrid S T Figueiredo; Lyara B N Freitas; Rachel S P Pinheiro; Gerly Anne C Brito; Nylane M N Alencar; Márcio V Ramos; Maria T Ralph; José V Lima-Filho Journal: Inflamm Res Date: 2012-04-10 Impact factor: 4.575
Authors: Jefferson S Oliveira; Letícia V Costa-Lotufo; Daniel P Bezerra; Nylane M N Alencar; José Delano B Marinho-Filho; Ingrid Samantha T Figueiredo; Manoel O Moraes; Claudia Pessoa; Ana Paula N N Alves; Márcio V Ramos Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2010-06-03 Impact factor: 3.000